Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388)
RATIONALE: The risk of recurrence following a stroke or transient ischemic attack is high, especially immediately after the event. HYPOTHESIS: Because two antiplatelet agents are superior to one in patients with non-cardioembolic events, more intensive treatment might be even more effective....
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015
|
| Online Access: | http://eprints.nottingham.ac.uk/37716/ http://eprints.nottingham.ac.uk/37716/ http://eprints.nottingham.ac.uk/37716/ http://eprints.nottingham.ac.uk/37716/1/Krishnan%20Int%20J%20Stroke%202015%2010%201159%20Safety%20and%20efficacy%20intensive%20v%20guideline%20antiplatelet%20therapy%20TARDIS.pdf |
Internet
http://eprints.nottingham.ac.uk/37716/http://eprints.nottingham.ac.uk/37716/
http://eprints.nottingham.ac.uk/37716/
http://eprints.nottingham.ac.uk/37716/1/Krishnan%20Int%20J%20Stroke%202015%2010%201159%20Safety%20and%20efficacy%20intensive%20v%20guideline%20antiplatelet%20therapy%20TARDIS.pdf